What is the recommended use of resorbable nasal packing after bilateral inferior turbinate submucosal resection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Resorbable Packing is Preferred for Bilateral Inferior Turbinate Submucosal Resection

Resorbable nasal packing should be used after bilateral inferior turbinate submucosal resection to minimize patient discomfort, reduce complications, and eliminate the need for painful pack removal. This approach offers superior quality of life outcomes compared to non-resorbable alternatives.

Rationale for Resorbable Packing

The 2020 AAO-HNS epistaxis guidelines explicitly recommend resorbable packing for patients with bleeding disorders or those on anticoagulant/antiplatelet medications 1. While these guidelines focus on epistaxis management, the principles directly apply to post-turbinate surgery hemostasis where bilateral mucosal surfaces are at risk.

Key Advantages of Resorbable Materials

Resorbable packing eliminates removal trauma, which is particularly important given the bilateral nature of turbinate reduction. The evidence demonstrates:

  • Significantly less bleeding on removal: Calcium alginate (Algosteril) caused statistically less bleeding compared to non-resorbable polyvinyl acetal (p=0.016) 2
  • Dramatically reduced pain: Pain scores were significantly lower with resorbable materials (p=0.0001) 2
  • Better mucosal healing: Resorbable hyaluronan packing showed improved re-epithelialization and reduced adhesion formation at 4 weeks (p=0.041) and 12 weeks (p<0.001) 3
  • Lower complication rates: Nasopore (resorbable) demonstrated the lowest pain scores and bleeding during both packing period and removal compared to non-resorbable alternatives 4

Critical Safety Consideration for Bilateral Packing

Bilateral nasal packing carries specific risks that favor resorbable materials. The guidelines explicitly warn that nasal septal perforation may occur with bilateral nasal packings 1. Non-resorbable packing increases this risk through:

  • Prolonged mucosal pressure (typically 48-72 hours) 1
  • Trauma during removal from both sides
  • Risk of synechiae formation from bilateral mucosal injury 1

Resorbable packing mitigates these risks by dissolving gradually with nasal saline irrigation, avoiding the bilateral removal trauma entirely 1.

Practical Implementation

Packing Protocol

  • Place resorbable packing (calcium alginate, hyaluronan-based, or Nasopore) bilaterally after turbinate resection
  • Instruct patients to use nasal saline sprays frequently throughout the day to facilitate dissolution 1
  • Schedule follow-up to monitor proper mucosal healing 1

Patient Education Requirements

Per guideline recommendations, educate patients that 1:

  • The packing will dissolve over time with saline use—no removal appointment needed
  • Expect temporary nasal obstruction, facial pressure, and decreased smell
  • Use acetaminophen for pain (avoid aspirin/ibuprofen)
  • Avoid nose blowing, straining, lifting >10 pounds, and strenuous exercise
  • Sleep with head elevated

Warning Signs Requiring Immediate Evaluation

  • Fever >101°F
  • Increasing pain
  • Vision changes
  • Shortness of breath
  • Return of significant bleeding
  • Facial swelling or diffuse rash 1

Duration and Hemostasis Considerations

While one older study suggested 48-hour packing reduced hemorrhage rates to 0% versus 11.7% with no packing 5, this must be balanced against the bilateral complication risk. Resorbable packing provides sustained hemostatic pressure without the fixed time constraints and removal trauma of non-resorbable materials, making it ideal for the bilateral surgical field where both inferior turbinates require simultaneous healing.

Antibiotic Prophylaxis

The decision for systemic antibiotics remains controversial and should be individualized 1. The guidelines note that while systematic reviews show no significant benefit, studies were underpowered to detect rare complications like toxic shock syndrome. Consider antibiotics if:

  • Prolonged packing duration anticipated
  • Patient has significant comorbidities
  • High infection risk factors present

However, resorbable packing's shorter effective duration and lack of removal trauma may reduce infection risk compared to traditional 48-72 hour non-resorbable packing.

Common Pitfall to Avoid

Do not use non-resorbable packing bilaterally for routine turbinate reduction. The combination of bilateral mucosal trauma, required removal procedure, and risk of septal perforation outweighs any theoretical hemostatic advantage, especially given that resorbable materials demonstrate equivalent bleeding control with superior patient outcomes 2, 3.

References

Guideline

clinical practice guideline: nosebleed (epistaxis).

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2020

Research

Endoscopic outcomes of resorbable nasal packing after functional endoscopic sinus surgery: a multicenter prospective randomized controlled study.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2009

Research

[Effects of four different nasal packing materials after endoscopic sinus surgery].

Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery, 2016

Research

Inferior turbinate resection: the need for a nasal pack.

The Journal of laryngology and otology, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.